DE9307393U1 - Tablet with improved bioavailability, containing dichloromethylene diphosphonic acid as an active ingredient - Google Patents

Tablet with improved bioavailability, containing dichloromethylene diphosphonic acid as an active ingredient

Info

Publication number
DE9307393U1
DE9307393U1 DE9307393U DE9307393U DE9307393U1 DE 9307393 U1 DE9307393 U1 DE 9307393U1 DE 9307393 U DE9307393 U DE 9307393U DE 9307393 U DE9307393 U DE 9307393U DE 9307393 U1 DE9307393 U1 DE 9307393U1
Authority
DE
Germany
Prior art keywords
tablet
active ingredient
diphosphonic acid
improved bioavailability
dichloromethylene diphosphonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE9307393U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE9307393U priority Critical patent/DE9307393U1/en
Priority to EP93917636A priority patent/EP0697890A1/en
Priority to CZ1995100A priority patent/CZ287984B6/en
Priority to SK48-95A priority patent/SK281193B6/en
Priority to AU47020/93A priority patent/AU687744B2/en
Priority to ES93111827T priority patent/ES2065313T5/en
Priority to PL93307133A priority patent/PL173026B1/en
Priority to DK93111827T priority patent/DK0625355T5/en
Priority to HU9403160A priority patent/HU220872B1/en
Priority to PCT/EP1993/001967 priority patent/WO1994026310A1/en
Priority to DE59300688T priority patent/DE59300688D1/en
Priority to BR9307859A priority patent/BR9307859A/en
Priority to UA95114854A priority patent/UA39884C2/en
Priority to KR1019950705094A priority patent/KR100263284B1/en
Priority to RU95121748A priority patent/RU2134103C1/en
Priority to NZ254765A priority patent/NZ254765A/en
Priority to CA002162470A priority patent/CA2162470C/en
Priority to JP51843194A priority patent/JP3699110B2/en
Priority to EP93111827A priority patent/EP0625355B2/en
Priority to US08/537,853 priority patent/US5650168A/en
Priority to AT93111827T priority patent/ATE128363T1/en
Priority to ZA936041A priority patent/ZA936041B/en
Priority to IL10674393A priority patent/IL106743A/en
Priority to TW082106635A priority patent/TW350772B/en
Priority to CN93118149A priority patent/CN1041797C/en
Publication of DE9307393U1 publication Critical patent/DE9307393U1/en
Priority to AT0007494U priority patent/AT128U1/en
Priority to FI945313A priority patent/FI111519B/en
Priority to NO944405A priority patent/NO307548B1/en
Priority to GR940300095T priority patent/GR940300095T1/en
Priority to GR950402574T priority patent/GR3017547T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
DE9307393U 1993-05-15 1993-05-15 Tablet with improved bioavailability, containing dichloromethylene diphosphonic acid as an active ingredient Expired - Lifetime DE9307393U1 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (en) 1993-05-15 1993-05-15 Tablet with improved bioavailability, containing dichloromethylene diphosphonic acid as an active ingredient
NZ254765A NZ254765A (en) 1993-05-15 1993-07-24 Tablet medicament; comprises dichloromethylene diphosphonic acid (clodronic acid) or a pharmaceutically acceptable salt thereof as active ingredient and microcrystalline cellulose as auxiliary
UA95114854A UA39884C2 (en) 1993-05-15 1993-07-24 CLODRONIC ACID-BASED TABLET, METHOD OF PRODUCTION AND TREATMENT OF OSTEOPOROSIS
SK48-95A SK281193B6 (en) 1993-05-15 1993-07-24 Tablet with enhanced biological availability of active substance i.e. clodronic acid, process for preparing thereof, use of microcrystalline cellulose
AU47020/93A AU687744B2 (en) 1993-05-15 1993-07-24 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
ES93111827T ES2065313T5 (en) 1993-05-15 1993-07-24 TABLET WITH IMPROVED BIODISPONIBILITY CONTAINING DICHLOROMETILENDIFOSFONICO ACID AS ACTIVE SUBSTANCE.
PL93307133A PL173026B1 (en) 1993-05-15 1993-07-24 Tablet of improved biological accessibility, containing dichloromethylene biphosphonic acid as active substance
JP51843194A JP3699110B2 (en) 1993-05-15 1993-07-24 Tablets with improved bioavailability containing dichloromethylene diphosphonic acid as active substance
HU9403160A HU220872B1 (en) 1993-05-15 1993-07-24 Tablets containing dichloromethylene diphosphonic acid as active agent with enhanced bioavailability and process for producing them
PCT/EP1993/001967 WO1994026310A1 (en) 1993-05-15 1993-07-24 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
DE59300688T DE59300688D1 (en) 1993-05-15 1993-07-24 Tablet with improved bioavailability containing dichloromethylene diphosphonic acid as active ingredient.
BR9307859A BR9307859A (en) 1993-05-15 1993-07-24 Improved bioavailability tablet that contains acid
CZ1995100A CZ287984B6 (en) 1993-05-15 1993-07-24 Tablet with enhanced biological availability of active substance i.e. clodronic acid and process for preparing thereof
KR1019950705094A KR100263284B1 (en) 1993-05-15 1993-07-24 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
RU95121748A RU2134103C1 (en) 1993-05-15 1993-07-24 Tablet exhibiting improved bioavailability of biologically active substance and substance enhancing bioavailability
EP93917636A EP0697890A1 (en) 1993-05-15 1993-07-24 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
CA002162470A CA2162470C (en) 1993-05-15 1993-07-24 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance
DK93111827T DK0625355T5 (en) 1993-05-15 1993-07-24 Tablet with improved bioavailability containing dichloromethylene diphosphonic acid as active substance
EP93111827A EP0625355B2 (en) 1993-05-15 1993-07-24 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient
US08/537,853 US5650168A (en) 1993-05-15 1993-07-24 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance
AT93111827T ATE128363T1 (en) 1993-05-15 1993-07-24 TABLET WITH IMPROVED BIOAVAILABILITY CONTAINING DICHLOROMETHYLENEDIPHOSPHONIC ACID AS THE ACTIVE INGREDIENT.
ZA936041A ZA936041B (en) 1993-05-15 1993-08-18 Tablets with improved bioavailability of the active material clodronic acid
IL10674393A IL106743A (en) 1993-05-15 1993-08-19 Tablets with improved bioavailability of the active material clodronic acid
TW082106635A TW350772B (en) 1993-05-15 1993-09-10 Tablets with improved bioavailability of the active material clodronic acid
CN93118149A CN1041797C (en) 1993-05-15 1993-09-23 Tablets with improved bioavailability of the active material clodronic acid
AT0007494U AT128U1 (en) 1993-05-15 1994-05-13 TABLET WITH IMPROVED BIOAVAILABILITY CONTAINING DICHLORMETHYLENE DIPHOSPHONIC ACID AS AN ACTIVE SUBSTANCE
FI945313A FI111519B (en) 1993-05-15 1994-11-11 Process for the preparation of a tablet containing dichloromethylene phosphonic acid as an active ingredient
NO944405A NO307548B1 (en) 1993-05-15 1994-11-17 Tablet with improved bioavailability containing dichloromethylene diphosphonic acid as active compound
GR940300095T GR940300095T1 (en) 1993-05-15 1995-01-31 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.
GR950402574T GR3017547T3 (en) 1993-05-15 1995-09-28 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (en) 1993-05-15 1993-05-15 Tablet with improved bioavailability, containing dichloromethylene diphosphonic acid as an active ingredient

Publications (1)

Publication Number Publication Date
DE9307393U1 true DE9307393U1 (en) 1993-11-04

Family

ID=6893321

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9307393U Expired - Lifetime DE9307393U1 (en) 1993-05-15 1993-05-15 Tablet with improved bioavailability, containing dichloromethylene diphosphonic acid as an active ingredient

Country Status (2)

Country Link
DE (1) DE9307393U1 (en)
ZA (1) ZA936041B (en)

Also Published As

Publication number Publication date
ZA936041B (en) 1995-02-20

Similar Documents

Publication Publication Date Title
KR970006279A (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compound as active pharmaceutical ingredient
NO179911C (en) Optically active 5H-pyrrolo [3,4-bpyrazine derivative as well as pharmaceutical preparations containing the derivative
DE68911473D1 (en) Drug formulations.
DE3887513T2 (en) CHEMICAL FORMULATIONS.
FI921312A0 (en) HOEGMOBILA INTEGRERADE DRIVERS FOER ACTIVE MATRISDISPLAYS.
DE59402194D1 (en) Fungicidal active ingredient combinations
DE59408221D1 (en) Fungicidal active ingredient combinations
DE59300688D1 (en) Tablet with improved bioavailability containing dichloromethylene diphosphonic acid as active ingredient.
DE69202362T2 (en) Cathode.
FI961437A (en) Active substance delivery system
DE69133371D1 (en) Pharmaceutical active benzoquinazoline compounds
MX9201969A (en) OPTIMIZED TABLET FORMULATION.
FR2683649B1 (en) DIGITALIZING TABLET.
FI933808A0 (en) INSECTICIDES ACTIVE PEPTIDER
FI922720A0 (en) PHARMACOLOGICALLY ACTIVE AMID CARBOXYLATERS.
ATE166229T1 (en) ANTITUSSIVE
IT8920405A0 (en) PHARMACOLOGICALLY ACTIVE AMINOIMIDAZOPYRIDINES.
DE9307393U1 (en) Tablet with improved bioavailability, containing dichloromethylene diphosphonic acid as an active ingredient
FI923371A (en) EN PHARMACEUTICAL FORMULATION.
AU4719489A (en) Controlled-release, low dose aspirin
DE59909714D1 (en) Effervescent tablet containing calcium with an antihistamine as active ingredient
DE68908838D1 (en) Pharmaceutically active dithiokete derivatives.
IT1229230B (en) PHARMACOLOGICALLY ACTIVE PIPERIDYLIMIDAZOPYRIDINS.
KR970000225A (en) Anti-depressant drug containing cinephrine as an active ingredient
SE9301141D0 (en) NEW ACTIVE COMPOUNDS IV